UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
British journal of dermatology (1951), ISSN 0007-0963, 11/2009, Volume 161, Issue 5, pp. 1199 - 1201
anakinra | PAPA (pyogenic arthritis, pyoderma gangrenosum and | pyoderma gangrenosum | interleukin-1 receptor antagonist | interleukin‐1 receptor antagonist | PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome | Anakinra | Interleukin-1 receptor antagonist | Pyoderma gangrenosum | Life Sciences & Biomedicine | Dermatology | Science & Technology | Miscellaneous. Osteoarticular involvement in other diseases | Biological and medical sciences | Medical sciences | Skin involvement in other diseases. Miscellaneous. General aspects | Diseases of the osteoarticular system | Pyoderma Gangrenosum - drug therapy | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Humans | Injections, Subcutaneous | Arthritis - drug therapy | Acne Vulgaris - drug therapy | Adult | Male | Treatment Outcome | Syndrome | Antirheumatic Agents - therapeutic use | Antiacne agents | Care and treatment | Corticosteroids | Interleukins | Pyoderma | Acne | Immunotherapy | Arthritis | Index Medicus
Journal Article
Orphanet journal of rare diseases, ISSN 1750-1172, 2007, Volume 2, Issue 1, pp. 19 - 19
Genetics & Heredity | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Cytotoxins - therapeutic use | Pyoderma Gangrenosum - physiopathology | Diagnosis, Differential | Prognosis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Anti-Infective Agents - therapeutic use | Child, Preschool | Infant | Male | Pyoderma Gangrenosum - therapy | Adrenal Cortex Hormones - therapeutic use | Adolescent | Adult | Female | Aged | Pyoderma Gangrenosum - diagnosis | Administration, Topical | Child | Pyoderma Gangrenosum - classification | Causes of | Care and treatment | Diagnosis | Pyoderma | Index Medicus
Journal Article
American journal of clinical dermatology, ISSN 1175-0561, 6/2012, Volume 13, Issue 3, pp. 191 - 211
Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | Tumour-necrosis-factor-alpha-inhibitors | Pyoderma-gangrenosum | Biological-products | Ciclosporin | Inflammation | Prednisone | Wound-healing | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Skin involvement in other diseases. Miscellaneous. General aspects | Hematologic Diseases - complications | Humans | Immunosuppressive Agents - therapeutic use | Pyoderma Gangrenosum - therapy | Adrenal Cortex Hormones - therapeutic use | Anti-Bacterial Agents - therapeutic use | Arthritis - complications | Pyoderma Gangrenosum - complications | Pyoderma Gangrenosum - etiology | Anti-Inflammatory Agents - therapeutic use | Pyoderma Gangrenosum - diagnosis | Inflammatory Bowel Diseases - complications | Biological Products - therapeutic use | Care and treatment | Pyoderma | Diagnosis | Research | Autoimmune diseases | Causes and theories of causation | Risk factors | Diseases
Journal Article
British journal of dermatology (1951), ISSN 0007-0963, 07/2017, Volume 177, Issue 1, pp. 72 - 83
Life Sciences & Biomedicine | Dermatology | Science & Technology | Drug Eruptions - etiology | Off-Label Use | Apoptosis - drug effects | Humans | Neutrophils - drug effects | Dermatologic Agents - therapeutic use | Pyoderma Gangrenosum - chemically induced | Epigenesis, Genetic - physiology | Cell Movement - drug effects | Keratinocytes - drug effects | Epidermal Growth Factor - antagonists & inhibitors | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Colony-Stimulating Factors - therapeutic use | Inflammation - physiopathology | Protein-Tyrosine Kinases - antagonists & inhibitors | Pyoderma | Tyrosine | Immune response | Leukocyte migration | Pathogenesis | Neutrophils | Leukocytes (neutrophilic) | Inflammation | Immunosuppressive agents | Epigenetics | Colony-stimulating factor | Protein-tyrosine kinase | Apoptosis | Pyoderma gangrenosum | Index Medicus
Journal Article
British journal of dermatology (1951), ISSN 0007-0963, 06/2017, Volume 176, Issue 6, pp. 1588 - 1598
Life Sciences & Biomedicine | Dermatology | Science & Technology | Skin - metabolism | Hidradenitis Suppurativa - metabolism | Humans | Middle Aged | Male | Autoimmune Diseases - genetics | Young Adult | Selectins - metabolism | Acne Vulgaris - metabolism | Hidradenitis Suppurativa - genetics | Adult | Female | Receptors, Cytokine - metabolism | Autoimmune Diseases - metabolism | Pyoderma Gangrenosum - metabolism | Cytokines - metabolism | Dermatitis - genetics | Mutation - genetics | Syndrome | Tissue Inhibitor of Metalloproteinases - metabolism | Adolescent | Acne Vulgaris - genetics | Aged | Pyoderma Gangrenosum - genetics | Matrix Metalloproteinases - metabolism | Leukocytes - metabolism | Dermatitis - metabolism | Skin | Interleukins | T cells | Pyoderma | Gastrointestinal diseases | Acne | Inflammatory bowel diseases | Cytokines | RANTES | Lymphocytes T | Leukocytes (neutrophilic) | Arthritis | Interleukin 17 | Cell activation | Intestine | Tumor necrosis factor | Ulcers | Interleukin 1 | Ligands | Skin diseases | Mutation | Chemokines | Interleukin 8 | NOD2 protein | Pyoderma gangrenosum | Tumors | Index Medicus
Journal Article
Clinics in dermatology, ISSN 0738-081X, 2015, Volume 33, Issue 5, pp. 527 - 530
Journal Article